Shinva Medical InstrumentLtd 관리

관리 기준 확인 3/4

Shinva Medical InstrumentLtd CEO는 Baoxian Gong, Feb2022 에 임명되었습니다 의 임기는 2.75 년입니다. 는 CN¥ 1.18M 가치에 해당하는 회사 주식의 0.011% 직접 소유합니다. 1.18M. 경영진과 이사회의 평균 재임 기간은 각각 3 년과 3.8 년입니다.

주요 정보

Baoxian Gong

최고 경영자

CN¥2.3m

총 보상

CEO 급여 비율	n/a
CEO 임기	2.8yrs
CEO 소유권	0.01%
경영진 평균 재임 기간	3yrs
이사회 평균 재임 기간	3.8yrs

최근 관리 업데이트

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

CEO

Baoxian Gong (48 yo)

2.8yrs

테뉴어

CN¥2,312,900

보상

Mr. Baoxian Gong is General Manager of Shinva Medical Instrument Co., Ltd., since February 23, 2022.

리더십 팀

이름	위치	테뉴어	보상	소유권
Baoxian Gong	General Manager	2.8yrs	CN¥2.31m	0.011% CN¥ 1.2m
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.026% CN¥ 2.8m
Cai Xiang Li	Deputy GM & Secretary of the Board	7.3yrs	CN¥978.80k	0.046% CN¥ 4.9m
Jing Qu	Deputy General Manager	4.6yrs	CN¥1.57m	0.028% CN¥ 3.0m
Jiaqiang Wang	Deputy General Manager	2.3yrs	CN¥1.23m	0.013% CN¥ 1.3m
Qingguo Zhu	Deputy General Manager	2.3yrs	CN¥1.64m	0.014% CN¥ 1.5m

3.0yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: 600587 의 관리팀은 경험 ( 3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.026% CN¥ 2.8m
Ailing Pan	Independent Director	4.3yrs	CN¥80.00k	데이터 없음
Yu Quan Wang	Chairman	4.5yrs	CN¥1.25m	0.046% CN¥ 4.8m
Weijun Gu	Independent Director	4.4yrs	CN¥80.00k	0.0014% CN¥ 146.6k
Hongtao Cui	Employee Representative Director	7.6yrs	CN¥2.60m	0.030% CN¥ 3.2m
Xiao Li Zhao	Director	7.6yrs	CN¥1.03m	데이터 없음
Yueyong Wang	Director	3.8yrs	CN¥33.30k	데이터 없음
Xiao Li Li	Director	3.8yrs	CN¥94.00k	데이터 없음
Li Yong Jiang	Independent Director	3.8yrs	CN¥80.00k	데이터 없음
Lehai Mou	Chairman of the Supervisory Board	3.8yrs	데이터 없음	데이터 없음
Yuan Li	Independent Director	3.3yrs	CN¥80.00k	데이터 없음
Fuquan Zhang	Director	1.3yrs	CN¥33.30k	데이터 없음

3.8yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 이사회: 600587 의 이사회는 경험(평균 재직 기간 3.8 년)으로 간주됩니다.

Shinva Medical InstrumentLtd 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령